Загрузка...
B7-H1 signaling is integrated during CD8(+) T cell priming and restrains effector differentiation
A promising strategy in tumor immunotherapy is the use of activated dendritic cells as vehicles for tumor vaccines with the goal of activating anti-tumor T cell responses. Current formulations for dendritic cell-based immunotherapies have limited effects on patient survival, providing motivation for...
Сохранить в:
| Опубликовано в: : | Cancer Immunol Immunother |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Berlin Heidelberg
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4833388/ https://ncbi.nlm.nih.gov/pubmed/24893858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-014-1563-6 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|